What Challenges Exist in Targeting Structural Proteins?
Targeting structural proteins poses several challenges. Pathogens can rapidly mutate, leading to changes in these proteins that may render treatments ineffective. Additionally, the structural complexity of these proteins can make it difficult to design drugs that specifically target them without affecting host proteins.